ErVimmune raises 17m euros in funding to develop cancer vaccine - PharmaTimes The vaccine could be created as a ready-to-use product, rather than needing to be personalised

#vaccinedevelopment #ErVimmune #biotech #cancervaccine #readytousevaccine #personalisedvaccines #celltherapies #cancervaccines #cancervaccinecandidate #ErVac01 #immunotherapies #coldtumours #triplenegativebreastcancer #ovariancancer #offtheshelfcancervaccine #difficulttotreatcancers
zurl.co/Z94ou